Health Committee

20 December 2004                  No 04, Session 2004-05


Inquiry into The Influence of the Pharmaceutical Industry

The Health Committee has arranged the following meeting, to be held in public:

Thursday 13 January 2005 in the Boothroyd Room  at 10:30  am

Oral evidence from:

[ at 10.30am]

Mr Eddie Gray, Senior Vice President and General Manager, GlaxoSmithKline Pharma (UK)

Dr Stuart Dollow, Vice President, Medical Division, GlaxoSmithKline (UK)

Mr Chris Brinsmead, Marketing Co-President, AstraZeneca (UK)

Dr John Patterson, Executive Vice President, Product Strategy, Licensing and Business Development, AstraZeneca (UK)

[at 11.45am]

Dr Richard Barker, Director General, Association of the British Pharmaceutical Industry

Mr Vincent Lawton, President, Association of the British Pharmaceutical Industry

Dr David Chiswell, Chairman, BioIndustry Association

Mr Simon Clark, Chair, British Generic Manufacturers Association.


Members of the public and representatives of the press will be admitted to these meetings. Because there are often last minute changes of rooms and meetings may be held either in the Palace of Westminster or Portcullis House, those wishing to attend should check the venue by contacting the House of Commons Public Information office on 020 7219 4272 the day before the meeting.

The Health Committee is a Select Committee of the House of Commons.  It is appointed under Standing Order No. 152 to examine the expenditure, administration and policy of the Department of Health and associated public bodies. The Committee has power to send for persons, papers and records.